Jpmorgan Chase & CO Acrivon Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,741 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,741

Previous 1,741 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	N/A	-6,738 Reduced 79.47%	1,741 $0
Q1 2025 May 12, 2025	SELL	N/A	-17,330 Reduced 67.15%	8,479 $0
Q4 2024 Feb 12, 2025	SELL	N/A	-8,182 Reduced 24.07%	25,809 $0
Q3 2024 Dec 26, 2024	BUY	N/A	28,748 Added 548.31%	33,991 $0
Q3 2024 Nov 08, 2024	BUY	N/A	28,748 Added 548.31%	33,991 $0

Q2 2024 Dec 26, 2024	SELL	N/A	-28,748 Reduced 84.58%	5,243 $0
Q2 2024 Aug 12, 2024	BUY	N/A	284 Added 5.73%	5,243 $0
Q1 2024 Dec 26, 2024	SELL	N/A	-29,032 Reduced 85.41%	4,959 $0
Q1 2024 May 10, 2024	SELL	N/A	-28,384 Reduced 85.13%	4,959 $0
Q4 2023 Dec 26, 2024	SELL	N/A	-648 Reduced 1.91%	33,343 $0
Q4 2023 Feb 12, 2024	BUY	N/A	6,771 Added 25.48%	33,343 $0
Q3 2023 Nov 14, 2023	BUY	N/A	19,645 Added 283.6%	26,572 $0
Q2 2023 Aug 11, 2023	BUY	N/A	297 Added 4.48%	6,927 $0
Q1 2023 May 18, 2023	BUY	N/A	6,630 New	6,630 $0

Others Institutions Holding ACRV

# of Institutions

Shares Held

18.2M

Call Options Held

Put Options Held

View Full List

About Acrivon Therapeutics, Inc.

Ticker ACRV

More about ACRV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Acrivon Therapeutics, Inc. Transaction History